MyoKardia
Total Raised
$94MInvestors Count
8Deal Terms
5Funding, Valuation & Revenue
5 Fundings
MyoKardia has raised $94M over 5 rounds.
MyoKardia's latest funding round was a Acq - P2P for on November 17, 2020.
MyoKardia's valuation in October 2015 was $262.42M.
MyoKardia's latest post-money valuation is from November 2020.
Sign up for a free demo to see MyoKardia's valuations in November 2020 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
11/17/2020 | Acq - P2P | 8 | ||||
10/29/2015 | IPO | $262.42M | ||||
4/30/2015 | Series B | |||||
8/22/2014 | Series A - II | |||||
9/20/2012 | Series A |
Date | 11/17/2020 | 10/29/2015 | 4/30/2015 | 8/22/2014 | 9/20/2012 |
|---|---|---|---|---|---|
Round | Acq - P2P | IPO | Series B | Series A - II | Series A |
Amount | |||||
Investors | |||||
Valuation | $262.42M | ||||
Revenue | |||||
Sources | 8 |
MyoKardia Deal Terms
5 Deal Terms
MyoKardia's deal structure is available for 5 funding rounds, including their Acq - P2P from November 17, 2020.
Round | Acq - P2P | IPO | Series B | Series A - II | Series A |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - P2P | |||||||||||||||
IPO | |||||||||||||||
Series B | |||||||||||||||
Series A - II | |||||||||||||||
Series A |
MyoKardia Investors
8 Investors
MyoKardia has 8 investors. Bristol-Myers Squibb invested in MyoKardia's Acq - P2P funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
11/17/2020 | 11/17/2020 | 1 Acq - P2P | Corporation | New Jersey | ||
Corporation | France | |||||
Investment Bank | New York | |||||
Hedge Fund | New York | |||||
Venture Capital | New York |
First funding | 11/17/2020 | ||||
|---|---|---|---|---|---|
Last Funding | 11/17/2020 | ||||
Investor | |||||
Rounds | 1 Acq - P2P | ||||
Board Seats | |||||
Type | Corporation | Corporation | Investment Bank | Hedge Fund | Venture Capital |
Location | New Jersey | France | New York | New York | New York |
Loading...